Abstract-Several environmental and genetic factors are believed to influence the onset of diabetes and its complications. It has also been established that cytokines play a key role in the pathogenesis of type 2 diabetes. Previous studies have revealed that the polymorphism at the stromal-derived factor 1β (SDF-1β) 3′A regulates the expression of SDF-1 (CXCL12). This study was aimed to explore this polymorphism in parallel with SDF-1 serum levels in type 2 diabetic patients. In this assessment, peripheral blood samples were collected from 200 type 2 diabetic patients and 200 healthy controls. DNA was extracted, and a PCR-RFLP screening was applied to examine the SDF-1β 3′A polymorphism. We also applied the ELISA technique to measure serum levels of SDF-1. Our results showed that there were no significant correlations between SDF-1β 3′Α polymorphism in type 2 diabetic patients when compared to controls. However, our results showed that the serum levels of SDF-1 were significantly increased in the patients when compared to controls. Based on the results of this study, we concluded that SDF-1β 3′Α polymorphism does not play a role in the pathogenesis of type 2 diabetes but that elevated serum levels of SDF-1 may be important for the etiology of type 2 diabetes but are unrelated to the SDF-1β 3′Α polymorphism.
INTRODUCTION
Type 2 diabetes is the most frequent type of diabetes, but its cause has yet to be clarified [1, 2] . The pathogenesis of type 2 diabetes involves environmental and inherited genetic parameters, and it is estimated that this latent disease will affect 365 million people by the year 2030 [1, 3] . It has been suggested that diabetes has characteristics of an immune disorder as highlighted by the pattern of variation in the profile of cytokine expression seen during the progression of the disease [4] . In type 2 diabetic patients, peripheral blood monocytes express more inflammatory cytokines than those from healthy subjects [5] . Cytokines and cytokine-receptor axis have recently been the focus of several studies due to their crucial roles in diabetes and its complications [6] , and the impact of cytokine imbalance in type 2 diabetes, with and without nephropathy, has been reported [7] . Increased serum levels of inflammatory cytokines including IL-18 [8] , IL-6 [9] , IL-17 [10] , IFN-γ [10] , and TNF-α [9] have been documented in type 2 diabetes and its nephropathic complications. Chemokines are a subgroup of cytokines with several biological effects such as recruitment of leukocytes to the sites of injury/infection and inflammation, angiogenesis, and angiostatic properties [11] . According to the presence of cysteine residues in their structure, they are classified as CC, CX 3 C, C, and CXC [12] . Stromalderived factor 1 (SDF-1), also known as CXCL12, fits into the CXC group [12] . The key roles of SDF-1 as an inhibitory chemokine in autoimmunity and inflammations raise questions concerning the impacts of this cytokine in the pathogenesis of some diseases including type 2 diabetes. We were also interested if there was a correlation between a known G801A polymorphism in the SDF-1β gene (SDF-1β 3′A) [13] [14] [15] and type 2 diabetes. Therefore, this study was aimed to investigate the serum levels SDF-1 in parallel with the SDF-1β 3′A polymorphism in a cohort of Iranian type 2 diabetic patients.
MATERIAL AND METHODS

Subject
Peripheral blood samples were collected from 200 type 2 diabetic patients and 200 healthy controls. Patients and controls were selected from within the Rafsanjan population with similar demographic characteristics including sex, age, and socioeconomic status ( Table 1) . Socioeconomic status was measured based on the monthly income. Monthly income lower than €200.00 was considered as weak, between €200.00-500.00 medium, and more than €500.00 high. All of the patients had the same nutritional status as well as exercise conditions. Patients had also similar disease severity because they were not suffering from either nephropathy, retinopathy, or other diabetes complications (Table 1) . Following three times testing of blood sugar, assays revealed that patients had serum levels between 140 and 190 mg/dl (Table 1) . Lipid levels, proteinuria, estimates of glomerular filtration rate (GFR), pharmacological intervention, and clinical history of the patients and controls are also listed in Table 1 . The ethical approval of this study was granted by the ethical committee of the Rafsanjan University of Medical Sciences, and all patients signed informed consent forms prior to sample collection.
DNA Extraction
Peripheral blood was collected in EDTA pre-coated tubes, and genomic DNA was extracted using commercial kits (Bioneer, South Korea). Extracted DNA samples were stored at −20°C for further use.
Polymorphism Studies
The G801A polymorphism in the SDF-1β gene (SDF-1β 3′A) was analyzed using polymerase chain reaction-restriction length polymorphism (PCR-RFLP) method described previously [11] . Briefly, PCR reaction mixtures were made by the addition of the following reagents to a 0.2-ml microcentrifuge tube on ice: 2.5 μl of Taq DNA polymerase buffer (10×), 0.5 μl of MgCl 2 (stock concentration, 1.5 mM), 0.5 μl of each dNTP 
Chemokine Assay
The serum levels of SDF-1 were measured by ELISA (R&D systems, UK) in patients and healthy controls immediately after blood collection. Assays were performed according to the manufacturer's guidelines. The sensitivity of kits was 2 pg/ml, and inter-and intraassay assessments of reliability of the kit were conducted. Data were only used when the inter-and intraassays produced scores of CV<14% and CV<0.03%, respectively.
Statistical Analysis
Hardy-Weinberg equilibrium was assessed using genotype data. Allele and genotype frequencies were calculated in patients and healthy controls by direct gene counting. Statistical analysis of the differences between groups was determined by χ 2 test using EPI 2000 and SPSS software version 13. A P value of less than 0.05 was considered significant. The study power was also calculated for each allele and genotype.
RESULTS
Statistical analysis of the demographic parameters indicated that the mean age, gender, and socio-economical status of the participants had no marked differences which were as follows: the mean age of patients was 40±6 years and that of the control group was 40±7 years (P=0.85), the gender split of the patients was 124 (62%) females and 76 (38%) males, and for the control group, it was 120 (60%) females and 80 (40%) males (P=0.9). In addition, there was no significant difference between groups regarding socio-economical status (P=0.90). Our results indicated that proteinuria was significantly increased (P=0.002), while estimated GFR was decreased (P<0.001) in type 2 diabetic patients when compared to controls ( Table 1) .
Evaluation of the G801A polymorphisms in SDF-1β by Sac-1 restriction digestion revealed that the prevalence of the A/A genotype was 16 (4.0%) in patients and 22 (5.5%) in controls. The frequency of A/ G genotype was 90 (22.5%) and 86 (21.5%) in patients and controls, respectively, and the frequency of the G/G genotype in patients was 94 (23.5%), and in controls, it was 92 (23%) ( Table 2 ). Statistical analysis of our data did not show a significant difference between the two groups (P>0.766). The frequency of A allele was 122 (15.3%) and 130 (15.3%) in patients and controls, respectively. Of the cases of G allele, 34.8% (278) were observed in patients, and the frequency of this allele was 270 (33.8%) in controls ( Table 2 ). Statistical analysis of alleles also did not exhibit a significant difference between patients and controls (P>0.893).
We observed a significant increase in the circulating serum levels of SDF-1 in type 2 diabetic patients (204.24 ± 30.85 pg/ml) in comparison to control (patients, 58±10 pg/ml) ( Fig. 1) (P<0.001) . 
DISCUSSION
The significant role(s) of cytokine network in the orientation of immune responses is well documented [10] . Several situations including infection, hormonal conditions, and cytokine gene polymorphisms have been described to regulate expression and secretion of cytokines [10] . The main etiological features of type 2 diabetes and its inflammatory complications, such as nephropathy, have yet to be identified. But it seems that the immune system plays important roles in etiology and pathogenesis of type 2 diabetes and its associated complications [10] . Therefore, the aim of the current to study was to investigate the potential correlation of the SDF-1β G801A polymorphism with type 2 diabetes. In addition, we measured the circulating serum levels of SDF-1 in type 2 diabetic patients to determine if its perturbation was associated with type 2 diabetes.
There were no significant differences between type 2 diabetic patients and healthy controls regarding genotypes and alleles of the +801 region of the SDF-1β gene. Therefore, based on the current study, it can be concluded that the +801 polymorphisms are not associated with type 2 diabetes in Iranian patients. To the best of our knowledge, this is the first study exploring the genetic variation of the SDF-1β gene in type 2 diabetic patients.
Our second aim was to explore the circulating serum levels of SDF-1 in patients and controls to determine if there was a correlation between SDF-1 serum levels and disease state. Our finding showed a very significant increase in circulating levels of SDF-1 in type 2 diabetic patients when compared to a matched health cohort of patients. Therefore, it seems that elevated SDF-1 production is not under effects of the gene polymorphisms and the disease status, epigenetic agents such as micro-RNAs, as well as environmental factors may play crucial roles on the chemokine expression. Another probable reason for the different SDF-1 expression may be related to the variable ability of mobilization of cells producing the chemokine in type 2 diabetes compared to healthy controls. Based on this fact, our patients were matched regarding the status of nutrition, exercise, pharmacological intervention, and duration of diabetes; hence, the factors could not affect serum levels of SDF-1 in the patients. Interestingly, there are some reports to show increased plasma levels of other CXC chemokines such as ENA78, Mig, IP-10, and IL-8 [16, 17] . In agreement with findings regarding the correlation of urine albuminuria and CXC chemokine SDF-1 levels, Wong and colleagues showed elevated levels of TNF-α, IL-10, IL-6, IL-18, as well as CXC chemokines such as IL-8 and Mig in diabetic patients [17] . We have already shown increased levels of SDF-1, Gro, and IP-10 as inducible chemokines following the stresses of heat shock [11] , under different stimuli and cytokine treatment in primary hepatocytes [11] and hepatoma cell lines [11] ; thus, the increased levels of this chemokine could be a result of similarity shock, as we have shown previously [18] . Alternatively, the changes in SDF-1 could be a response to increased levels of TNF-α, IFN-γ, IL-17 and other related inflammatory cytokines [10, 11] .
Taking together, the results of our current work in combination with previous studies confirm that the aberrant expression of inflammatory cytokines may be the underlying immunological mechanism involved in the development of type 2 diabetes. In agreement with our results, a previous study had shown that inhibition of SDF-1 led to decreased glomerulosclerosis, the podocyte number, and also albuminuria [19] . Collectively, we can probably conclude from our data and those of Sayyed SG (2009) that SDF-1 could be used as a therapeutic target to reduce diabetic complications (e.g. nephropathies). Moreover, our findings suggest that SDF-1 may be involved in the progression of human type 2 diabetes and that SDF-1 may also be used as a useful marker to distinguish diabetic complications such as nephropathy from primary renal diseases. and genetic factors, and these aspects of the disease should be examined in further studies in parallel with the current findings.
